Coloplast
kr 412.50Change from previous close: −0.67%Absolute change: −kr 2.80
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- kr 92.96B
- Enterprise value
- kr 116.5B
- P/E (trailing 12 months)
- 33.7
- Forward P/E
- 15.8
- PEG
- 1.06
- Price/book
- 6.95
- Price/sales
- 3.27
- EV/EBITDA
- 13.5
- EV/revenue
- 4.10
Profitability and growth
- Gross margin
- 67.2%
- Operating margin
- 26.2%
- Net margin
- 9.7%
- ROE
- 18.5%
- ROA
- 10.1%
- ROIC
- 14.7%
- Revenue growth (year over year)
- 5.7%
- Earnings growth (year over year)
- 81.8%
Financial health
- Total cash
- kr 817M
- Total debt
- kr 23.8B
- Debt/equity
- 1.78
- Current ratio
- 1.56
- Quick ratio
- 0.88
- Altman Z-Score
- 3.78
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- kr 23.00
- Dividend yield
- 5.5%
- Payout ratio
- 187.6%
- Ex-dividend date
- May 18, 2026
Analysts and estimates
- Average price target
- kr 468.29
- Median price target
- kr 455.00
- High price target
- kr 625.00
- Low price target
- kr 377.00
- Analysts with a price target
- 21
- Consensus
- Hold
- Forward EPS
- kr 26.05
- EPS estimate, current year
- kr 24.83
Shares and trading
- Beta
- 0.56
- Average volume
- 331.8K
- Shares outstanding
- 207.37M
- Float
- 144.57M
- Institutional ownership
- 32.8%
- Insider ownership
- 29.8%